Articles published by Innate Pharma SA
![](https://mms.businesswire.com/media/20240724437589/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240617573971/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240616126553/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240603023665/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Mycosis Fungoides
June 04, 2024
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20240527633153/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240523437811/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240523962373/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240520624001/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240514484777/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240513799097/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240506536913/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240414715190/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240414041043/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240409930250/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240408367312/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240404734878/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240320850157/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240318752264/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240313490063/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
March 14, 2024
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20240305421795/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
March 06, 2024
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20240305907062/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240220117014/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20240103221044/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
January 04, 2024
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20240103077864/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
January 04, 2024
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231218427387/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
December 19, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231217787253/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma Announces Leadership Change
December 18, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231210199351/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20231209939521/en/1245155/22/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20231126099215/en/1245155/22/INNATEvertnoirDS.jpg)
Innate Pharma to Host Virtual KOL Event on Lacutamab
November 27, 2023
From Innate Pharma SA
Via Business Wire
Tickers
IPHA
![](https://mms.businesswire.com/media/20231113498888/en/1245155/22/INNATEvertnoirDS.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.